Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

NCT00002753 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

RADIATION: iodine I 131 monoclonal antibody 81C6

Sponsor

Duke University